GlassScriptPhysician profile
Joan I Keit
NPI 1043261639
$290.68
in general payments reported to CMS, 2019-2025
7 companies · $29.10 in 2025
The $29.10 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2022: $4.25 · 2023: $95.95 · 2024: $15.94 · 2025: $29.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $125.41 | 2019-2023 | Elekta Medical Linear Accelerator |
| Accuray Incorporated | $86.75 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $18.00 | 2023 | Aria Radiation Therapy Management Software |
| Astrazeneca Pharmaceuticals LP | $17.85 | 2025 | Lynparza |
| Regeneron Healthcare Solutions, INC. | $15.94 | 2024 | Libtayo |
| Varian Medical Systems, INC. | $15.48 | 2019 | |
| Iovance Biotherapeutics, INC. | $11.25 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Keit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.